Abstract
The application of Quality by Design (QbD) requires that the distribution process be widely known across the development and operational components in the company. Currently, few companies have this process in mind during the development of the product. The adoption of a risk-based approach compares and contrasts the capability of the distribution process with the demonstrated requirements of the product. Regulators and industry-leading companies are now recognizing the creation of product design space, and the evaluation of physical stability early in the product life cycle. Leading academic institutions are demonstrating the relationship between physical stability of the product and the unavoidable physical hazards inherent in the distribution system. Application of QbD principles focused on defining the product design space for physical stability will accelerate product development and provide valuable insights to effective commercialization activities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moore WV, Leppert P (1980) Role of aggregated human growth-hormone (Hgh) in development of antibodies to Hgh. J Clin Endocrinol Metab 51(4):691–697
Murphy MM, Swarts S, Mueller BM, Geer P van der, Manning MC, Fitchmun MI (2013) Protein instability following transport or storage on dry ice. Nat Methods 10:278–279
Ratner RE, Phillips TM, Steiner M (1990) Persistent cutaneous insulin allergy resulting from high molecular weight insulin aggregates. Diabetes 39:728
Schellekens H (2002) Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin Ther 24(11):1720–1740
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Harber, P. (2015). Quality by Design for Distribution of Environmentally Sensitive Pharmaceutical Products. In: Jameel, F., Hershenson, S., Khan, M., Martin-Moe, S. (eds) Quality by Design for Biopharmaceutical Drug Product Development. AAPS Advances in the Pharmaceutical Sciences Series, vol 18. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2316-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2316-8_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2315-1
Online ISBN: 978-1-4939-2316-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)